Objective: To evaluate the altered findings of hepatic arteriography after radiofrequency (RF) ablation of hepatocellular carcinoma which can potentially influence subsequent transcatheter arterial chemoembolization. Materials and methods: Hepatic arteriograms of 26 index hepatocellular carcinomas in 24 patients treated only by RF ablation (M:F = 22:2, mean age 55 years), in which hepatic arteriography was performed before and after RF ablation, were retrospectively compared for the altered findings. Results: The altered findings of hepatic arteriography after RF ablation of the hepatocellular carcinoma were arterio-portal shunt (n = 3), periablational enhancement (n = 5), varied caliber of the feeding artery to the index tumor (n = 12) among which eight decreased, and occlusion of an adjacent arterial branch (n = 8). Residual unablated or locally progressed tumor was not detected in post-RF ablation arteriography (n = 5) due to the arterio-portal shunt (n = 2) or the periablational enhancement (n = 3). The possibility of not detecting the residual unablated or locally progressed tumor was higher within 24 weeks after RF ablation (Mann-Whitney test, P = 0.041). Conclusion: The findings of hepatic arteriography are altered after RF ablation, and the altered findings may increase the difficulty in performing super-selective transcatheter arterial chemoembolization due to undetected tumor staining, decreased caliber, or occlusion of the feeding artery.
Hepatocellular carcinoma is a malignant neoplasm of the liver and commonly occurs in patients with cirrhosis. Surgical resection remains the gold standard of therapy, but only 20% are eligible for surgical resection due to the decreased hepatic reserve or the unresectable location [1] [2] [3] [4] . In these patients with poor hepatic reserve and hepatocellular carcinoma confined to the liver, minimally invasive therapy is considered as an alternative treatment.
Radiofrequency (RF) ablation and transcatheter arterial chemoembolization are among the widely used minimally invasive techniques in the treatment of unresectable hepatocellular carcinomas [5] [6] [7] [8] [9] [10] . RF ablation produces localized coagulation of the tumor by the heat induced by alternating electric current. Transcatheter arterial chemoembolization produces ischemic necrosis of the tumor by selective embolization of the hepatic arterial supply. Transcatheter arterial chemoembolization can be performed before RF ablation to reduce tumor perfusion and heat loss [11, 12] , and transcatheter arterial chemoembolization can be performed after RF ablation in the treatment of locally progressed tumor or newly developed focus of tumor in the liver.
The treatment by RF ablation may alter the findings of hepatic arteriography, which may influence the procedure of transcatheter arterial chemoembolization. The computed tomography (CT) and the ultrasonographic findings of the RF ablation zone and the locally progressed tumor after RF ablation have been reported [13] [14] [15] [16] [17] . The findings of hepatic arteriography after RF ablation have been reported only in a small number while reporting a large series of patients who underwent RF ablation [18, 19] . The purpose of this study was to evaluate the altered findings of hepatic arteriography after RF ablation of the hepatocellular carcinoma, which can potentially influence subsequent transcatheter arterial chemoembolization, by comparing the pre-RF ablation arteriograms and the post-RF ablation arteriograms.
Materials and methods

Patient population
We retrospectively evaluated the hepatic arteriograms performed before and after RF ablation of the hepatocellular carcinoma since August 1999. During this period, 26 index hepatocellular carcinomas in 24 patients underwent pre-RF ablation hepatic arteriography prior to performing CT during arterial portography and CT hepatic angiography, RF ablation of the hepatocellular carcinoma as the sole treatment, and post-RF ablation hepatic arteriography during follow-up. Informed consent was obtained from all patients. But since the hepatic arteriography and the RF ablation were performed for evaluation and treatment of the hepatocellular carcinomas, and since this is a retrospective study, by the policy of our institution, approval by the institutional review board was not required.
The patients were 22 males and two females and ranged in ages from 41 to 75 years (mean 55 years). All patients had underlying liver cirrhosis, of which 19 patients were hepatitis B viral carriers, one patient was a hepatitis C viral carrier, three patients had alcoholic liver cirrhosis, and one patient had cryptogenic liver cirrhosis.
The index hepatocellular carcinomas were diagnosed by operation in three, biopsy in nine, elevated alphafetoprotein (>400 ng/mL) in three, and clinical findings in 11 tumors. The radiological diagnoses of the CT, the hepatic arteriography and the CT during arterial portography and CT hepatic angiography were consistent with hepatocellular carcinoma in all index tumors. Among the 26 index tumors, 18 index tumors were initially diagnosed hepatocellular carcinoma during followup for liver cirrhosis, whereas 8 index tumors were newly developed focus of hepatocellular carcinoma at a different segment during follow-up after previous diagnosis and treatment of the hepatocellular carcinoma. Treatments performed for previously diagnosed hepatocellular carcinomas were hepatic segmentectomy in one, RF ablation in two, and transcatheter arterial chemoembolization in five tumors.
To exclude the effect of previously performed or combined therapy on the findings of hepatic arteriography, patients were excluded when the hepatocellular carcinoma was a locally progressed tumor at the margin of a previous treatment or when the interval from termination of previous treatment to pre-RF hepatic arteriography was less than 1 year. Patients with any local or systemic treatment other than RF ablation between the pre-RF ablation hepatic arteriography and the post-RF ablation hepatic arteriography were also excluded.
RF ablation technique
The RF ablation was performed using the internally cooled electrode (Radionics Inc., Burlington, MA, USA) or the multitined expandable electrode (Rita Medical Systems, Mountain View, CA, USA), 1-33 days (mean 10 days) after the pre-RF ablation hepatic arteriography. The RF energy was applied 1-15 times (mean 4.3 times) in 1-5 sessions (mean 1.6 sessions) of ablation. The electrodes were targeted under ultrasonographic or CT guidance, percutaneously in 25 ablations, and intraoperatively in one ablation.
Angiography technique
The pre-RF ablation hepatic arteriography was performed immediately before the CT during arterial portography and CT hepatic angiography in the 26 index hepatocellular carcinomas. The post-RF ablation hepatic arteriography was performed when local tumor progression or a new focus of tumor was suspected on CT during follow-up, while performing transcatheter arterial chemoembolization in 19, and follow-up CT during arterial portography and CT hepatic angiography in seven index tumors, 2 days to 108 weeks (mean 23 weeks) after the RF ablation.
After the femoral arterial access, selective arteriography of the superior mesenteric artery and the celiac artery in postero-anterior projection, and selective arteriography of the common hepatic artery or the proper hepatic artery in postero-anterior projection and right anterior oblique projection (25-30°) were performed. Selective arteriography of the aberrant hepatic artery was also performed when present. The arteriography was performed using the digital subtraction angiography technique, using a 5-Fr Rosch hepatic catheter (Cook, Bloomington, USA) or a 5-Fr Rosch hepatic H catheter (Cook). On the average, 80-90 mL of the iodinated contrast material iodixanol (Visipaque; Nycomed Ireland, Cork, Ireland) was administered for the hepatic arteriography.
The pre-RF ablation hepatic arteriograms and the post-RF ablation hepatic arteriograms were evaluated for the altered findings of the hepatic arteriography after the RF ablation.
Results
Post-RF ablation hepatic arteriograms revealed local tumor progression in nine, both local tumor progression and new focus of tumor in nine, and only new focus of tumor without local tumor progression in six index hepatocellular carcinomas. Two patients had no evidence of recurrent tumor on hepatic arteriography, CT during arterial portography and CT hepatic angiography, and further follow-up of 12 months.
The altered findings of the hepatic arteriography after RF ablation of the tumors were arterio-portal shunt (n = 3), periablational enhancement (n = 5), varied caliber of the feeding artery to the index tumor (n = 12), and occlusion of an adjacent arterial branch (n = 8). The arterio-portal shunt was seen in post-RF ablation hepatic arteriography performed 2 days to 15 weeks (mean 6 weeks) after the RF ablation. The severity of the arterio-portal shunt was lobar (Fig. 1) to subsegmental, and increased as the interval from RF ablation was shorter. The periablational enhancement was seen in post-RF ablation hepatic arteriography performed 7-28 weeks (mean 20 weeks) after the RF ablation (Fig. 2) , completely (n = 2) or partially (n = 3) encircling the ablation zone. The feeding artery to the index hepatocellular carcinoma identified on pre-RF ablation arteriogram (n = 19) was seen to supply the ablation zone or the locally progressed hepatocellular carcinoma in the post-RF ablation arteriograms, and completely disappeared (n = 2), decreased in caliber (n = 8) (Fig. 3) , increased in caliber (n = 2), and showed no change in caliber (n = 7). Occlusion of an adjacent bystander subsegmental arterial branch was also seen (Fig. 4) .
Residual unablated or locally progressed hepatocellular carcinoma was detected 2 days to 108 weeks (mean 23 weeks) after RF ablation in 18 patients. Among them, the tumors suspected on CT could not be detected in five patients (26.3%). They were due to the arterio-portal shunt or the periablational enhancement ( Table 1 ). The possibility of not detecting the residual unablated or locally progressed tumor was higher when the post-RF ablation hepatic arteriography was performed within 24 weeks after the RF ablation (Mann-Whitney test, P = 0.041).
Discussion
The RF ablation produces localized and controlled tumor destruction by thermal injury induced by the RF electrode. Various vascular complications after RF ablation are reported and they are peritoneal bleeding, hemothorax, subcapsular hematoma, intratumoral hematoma, hemobilia, portal hypertension, arterioportal fistula or shunt, portal vein thrombosis, and thrombosis of inferior vena cava [9, 18] . Although not all, the vascular complications can alter the findings of hepatic arteriography, and affect the procedure of transcatheter arterial chemoembolization performed after RF ablation for the locally progressed or newly developed focus of hepatocellular carcinoma.
The arterio-portal shunt may develop spontaneously in a cirrhotic liver due to the structural distortion, the hepatocellular carcinoma infiltrating the portal vein, or iatrogenically along the path of a biopsy needle after a liver biopsy procedure. When severe arterio-portal shunt is complicated by the hepatocellular carcinoma infiltrating the portal vein, transcatheter arterial chemoembolization is usually not performed due to the high risk of intrahepatic metastasis, complications by portal hypertension and hepatic infarction after chemoembolization. But the arterio-portal shunt occurring after puncturing the liver with a needle tended to close spontaneously in time and the frequency depended on the interval between the needle puncture and the hepatic arteriography [20] . It is not certain whether the arterio-portal shunts which developed after RF ablation have been induced by the procedure of puncturing the liver with the RF electrode or by the thermal injury. But the three arterio-portal shunts in our study were seen in hepatic arteriograms with short interval from the RF ablation to the hepatic arteriography, and was most severe as the interval was shorter. The arterio-portal shunts occurring after RF ablation may be related to puncturing the liver with the electrode rather than the thermal injury. They may have closed spontaneously in time, explaining the low overall incidence, and relatively more severe arterio-portal shunt as the interval from the RF ablation was shorter (Fig. 1) .
Although the arterio-portal shunt induced by puncturing the liver with a needle did not affect the rate of response of hepatocellular carcinoma to the transcatheter arterial chemoembolization [21] , the reported arterioportal shunts were not severe and were subsegmental in the degree. When the arterio-portal shunt is severe, the staining of the residual unablated or daughter nodules of the index hepatocellular carcinoma adjacent to the ablation zone can be hidden within the staining of the arterio-portal shunt, and localization for super-selective transcatheter arterial chemoembolization can be difficult. Furthermore, the iodized oil/doxorubicin emulsion will bypass the arterio-portal shunt and selective uptake by the hepatocellular carcinoma will be prohibited (Fig. 1) .
The periablational enhancement seen in the contrast enhanced CT correlated with a rim constituting a mixture of viable hepatic parenchyma, necrosis, and hemorrhage [13] . The enhancement was hyper-attenuating in the arterial phase, and differentiation from the locally progressed hepatocellular carcinoma was difficult. The frequency of the periablational enhancement also depended upon the interval from the RF ablation to the CT, and persisted as long as 6 months after the RF ablation [17] . Similar to previously reported CT finding, the periablational enhancement could be seen on hepatic arteriography performed as long as 28 weeks after the RF ablation. The periablational enhancement was seen as a band encircling the ablation zone in a variable degree, but in some arteriograms, the periablational enhancement could not be differentiated from the heterogeneous hepatogram resulting from the cirrhosis. It maybe due to the fact that multiple applications of RF energy or even multiple sessions are required to ablate most tumors, resulting in amorphous periablational enhancement, indistinguishable from the heterogeneous hepatogram. This may also be the reason for the relatively low incidence of the periablational enhancement detected in the post-RF ablation hepatic arteriogram Another focus of tumor was present at segment 6 (not shown). Two sessions of percutaneous ultrasonography-guided RF ablation of the tumor at segment 7 was performed, but was poorly targeted due to the iso-echogenicity of the tumor. C Transcatheter arterial chemoembolization was performed 2 days after the RF ablation for the residual unablated tumor, but severe arterio-portal shunt has developed. The staining of the hepatocellular carcinomas is embedded within the arterioportal shunt and is not seen. The liver function was preserved and selective embolization of the arterio-portal shunt was not performed. D Unenhanced CT scan performed 1 day after transcatheter arterial chemoembolization shows that most of the iodized oil/doxorubicin emulsion has bypassed the arterioportal shunt, and is deposited at subcapsular region. Small amount of iodized oil emulsion is deposited at the focus of hepatocellular carcinoma of segment 8. E Sixteen month follow-up hepatic arteriography (not included in the post-RF ablation hepatic arteriography due to the prior transcatheter arterial chemoembolization) after additional six sessions of RF ablation for the residual unablated and locally progressed hepatocellular carcinoma shows spontaneous closure of the arterio-portal shunt.
compared to the incidence reported in CT. The staining of a locally progressed hepatocellular carcinoma could also be hidden within the periablational enhancement (Fig. 2) .
The caliber of an artery will vary with the arterial demand of the tissue the artery is supplying. When the size of the locally progressed hepatocellular carcinoma of the post-RF ablation hepatic arteriography has varied compared to the index hepatocellular carcinoma, the caliber of the feeding artery will also change over time (Fig. 3) . The advances of the quality and decreased caliber of the microcatheters manufactured recently have made super-selective transcatheter arterial chemoembolization feasible, and most feeding arteries to the hepatocellular carcinoma can be super-selected easily. But as the caliber of a feeding artery to a locally progressed hepatocellular carcinoma decreases, the difficulty of super-selective transcatheter arterial chemoembolization will increase, along with increased chance of arterial dissection or spasm during the procedure.
When RF ablation of a tumor is performed, some amount of the normal liver parenchyma surrounding the tumor is also ablated to acquire the ablative margin. When a blood vessel of substantial size is located within the ablated normal liver parenchyma, the tissue adjacent to the blood vessel can be cooled during the RF ablation, resulting in the heat sink effect. The shape of the ablation zone will be altered away from the blood vessel, and the overall size diminished due to the removal of heat by flowing blood [22] . But there was a transition zone of 2-4 mm diameter of the blood vessel in which the heat overflowed the heat sink effect during ablation, resulting in vessel wall injury such as the endothelial cell necrosis and luminal thrombosis [23] . In addition, even if the RF ablation did not occlude the adjacent hepatic artery, a subsegmental artery adjacent to the index hepatocellular carcinoma can be supplying the normal liver parenchyma included in the ablative margin, especially at subcapsular region, resulting in diminished demand of the arterial supply. Occlusion of a subsegmental artery adjacent to the index hepatocellular carcinoma may have resulted from the thermal injury by the RF ablation, the direct mechanical trauma by the electrode, or the diminished demand by the liver parenchyma adjacent to the index tumor. When an artery is occluded in the deep region of liver parenchyma, intra-hepatic collaterals will supply the parenchyma distal to the occluded artery (Fig. 4) . A new focus of hepatocellular carcinoma developing distal to the occluded artery, will be supplied by the intra-hepatic collaterals, and increase the difficulty of super-selective transcatheter arterial chemoembolization. There are some limitations in the results of our study. The study was retrospectively designed and is descriptive. Hepatocellular carcinomas were pathologically diagnosed in only 12 patients. Locally progressed or recurrent hepatocellular carcinomas after RF ablation were radiologically diagnosed, but not pathologically diagnosed. The post-RF ablation hepatic arteriography was performed when recurrent hepatocellular carcinoma was suspected on follow-up liver CT scans resulting in a selection bias and the timing of post-RF ablation hepatic arteriography is diverse. The arterio-portal shunt and the occlusion of adjacent bystander subsegmental artery may Fig. 3 . A 75-year-old woman with hepatocellular carcinoma at segment 6. A Arterial phase hepatic arteriogram performed during CT arterial portography and CT hepatic angiography shows the staining of the hepatocellular carcinoma. B Hepatic arteriogram performed 8 weeks after RF ablation shows the staining of the locally progressed hepatocellular carcinoma. The feeding artery to the tumor has decreased in caliber (arrow) compared to the pre-RF ablation hepatic arteriography. Fig. 4 . A 48-year-old man with hepatocellular carcinoma at segment 3. A Hepatic arteriography performed during CT during arterial portography and CT hepatic angiography shows the staining of the hepatocellular carcinoma at segment 3 (arrow). Two sessions of percutaneous ultrasonography-guided RF ablation were performed. B Hepatic arteriography follow-up CT during arterial portography and CT hepatic angiography performed 44 weeks after RF ablation shows no locally recurrent tumor staining. Occlusion of an adjacent bystander arterial branch (large arrowhead) and filling of the distal artery (small arrowheads) by the intra-hepatic collaterals is seen.
have been induced by the mechanical trauma by the RF electrode, and not by the thermal injury of the RF ablation procedure and the changes of the portal vein and the hepatic vein could not be evaluated.
In conclusion, the altered findings of hepatic arteriography after RF ablation of the hepatocellular carcinoma were arterio-portal shunt, periablational enhancement, varied caliber of the feeding artery to the locally progressed hepatocellular carcinoma, and occlusion of an adjacent bystander subsegmental artery. The arterio-portal shunt and the periablational enhancement may hide the tumor staining of a residual unablated or locally progressed hepatocellular carcinoma adjacent to the ablation zone when the interval from the RF ablatin to the post-RF ablation hepatic arteriography is short. The altered findings may increase the difficulty in performing super-selective transcatheter arterial chemoembolization due to undetected staining of the residual unablated or locally progressed tumor, decreased caliber or occlusion of the feeding artery.
Interventional radiologists must be aware of these altered findings of hepatic arteriography after RF ablation and that the altered findings can increase the difficulty in performing super-selective transcatheter arterial chemoembolization of the residual unablated or locally progressed hepatocellular carcinoma after RF ablation. 
